Quercetin

On the Treatment of Covid-19 – Swiss Policy Research

On the Treatment of Covid-19 – Swiss Policy Research

Based on the available scientific evidence and current clinical experience, the SPR Collaboration recommends that physicians and authorities consider the following covid-19 treatment protocol for the prophylactic and early treatment of people at high risk or high exposure.

Numerous international studies have shown that prophylactic and early treatment can significantly reduce the risk of severe and fatal covid-19 (see scientific references below).

read more
Quercetin and Vitamin C: Synergistic Therapy for COVID-19

Quercetin and Vitamin C: Synergistic Therapy for COVID-19

Quercetin was initially found to provide broad-spectrum protection against SARS coronavirus in the aftermath of the SARS epidemic that broke out across 26 countries in 2003.1,2,3 Now, some doctors are advocating its use against SARS-CoV-2, in combination with vitamin C, noting that the two have synergistic effects.

Incidentally, ascorbic acid (vitamin C) and the bioflavonoid quercetin (originally labeled vitamin P) were both discovered by the same scientist – Nobel prize winner Albert Szent-Györgyi.4,5 Quercetin’s antiviral capacity has been attributed to five main mechanisms of action:

read more